Thomas Wehler
Impact in
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
Papers in
-
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 6
- Oncology 17
- Cancer Immunotherapy and Biomarkers 7
- Cancer survivorship and care 4
- Colorectal Cancer Treatments and Studies 3
- Chemokine receptors and signaling 2
- Co-authors
- Massimo Busin (1 shared paper)Nicolas Johannes Dickgreber (3 shared papers)Amanda Tufman (2 shared papers)Martin Schütz (1 shared paper)Petra Hoffknecht (2 shared papers)Monika Heidi Serke (1 shared paper)Theo Pelzer (1 shared paper)Angela Märten (1 shared paper)
- Journals
- Annals of Oncology (14 papers)Journal of Clinical Oncology (3 papers)BMC Cancer (2 papers)Lung Cancer (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Thomas Wehler
44 papers receiving 1.6k citations
Thomas Wehler's Hit Papers
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 739
- Oncology 463
- Immunology 152
- Ophthalmology 59
- Molecular Biology 261
Countries citing papers authored by Thomas Wehler
This map shows the geographic impact of Thomas Wehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wehler more than expected).
Fields of papers citing papers by Thomas Wehler
This network shows the impact of papers produced by Thomas Wehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wehler. The network helps show where Thomas Wehler may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Wehler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 229 | |
| 2 | 2019 | 192 | |
| 3 | Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study Hit paper breakdown → | 2024 | 136 |
| 4 | 2014 | 125 | |
| 5 | 2015 | 114 | |
| 6 | Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study Hit paper breakdown → | 2024 | 89 |
| 7 | 1999 | 79 | |
| 8 | 2016 | 77 | |
| 9 | 2021 | 71 | |
| 10 | 2020 | 69 | |
| 11 | 2018 | 68 | |
| 12 | 2016 | 53 | |
| 13 | 2014 | 51 | |
| 14 | 2017 | 44 | |
| 15 | 2006 | 34 | |
| 16 | 2018 | 30 | |
| 17 | 2012 | 26 | |
| 18 | 2019 | 25 | |
| 19 | 2016 | 17 | |
| 20 | 2022 | 17 |
About Thomas Wehler
Thomas Wehler is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Dermatology and Ophthalmology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer survivorship and care (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Immunotherapy and Immune Responses (2 papers), Chemokine receptors and signaling (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (739 citations), Oncology (463 citations), Immunology (152 citations), Ophthalmology (59 citations) and Molecular Biology (261 citations). Thomas Wehler has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Massimo Busin, Nicolas Johannes Dickgreber, Amanda Tufman, Martin Schütz, Petra Hoffknecht, Monika Heidi Serke, Theo Pelzer, Angela Märten, Rainer Gerhard Wiewrodt and Rudolf Maria Huber. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, BMC Cancer, Lung Cancer and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.